Table 1 Patient demographics and disease characteristics at baseline (prior to initiation of IVT-AFL).

From: Two-year outcomes of intravitreal aflibercept in a Swiss routine treat and extend regimen for patients with neovascular age-related macular degeneration

Demographic parameter/disease characteristic

EFF Set (n = 160)

Age at baseline [years]

 Median (min, max)

81 (58, 97)

 Mean (SD)

80.9 (8.3)

Gender

n (%)

 Female

89 (55.6)

 Male

71 (44.4)

Type of choroidal neovascularisation at baseline

n (%)

 Occult

102 (63.8)

 Predominantly classic

27 (16.9)

 Polypoidal choroidal vasculopathy

13 (8.1)

 Minimally classic

9 (5.6)

 Retinal angiomatous proliferation

3 (1.9)

 Missing

6 (3.8)

Disease features at baseline

n (%)

 Haemorrhage

41 (25.6)

 Pigment epithelial detachment

116 (72.5)

 Subretinal fluid

125 (78.1)

 Cystoid intraretinal fluid

92 (57.5)

 RPE rip

3 (1.9)

Baseline BCVA

 ETDRS letter score, Mean (SD)[letters]

61.5 (20.1)

 Approximate Snellen equivalent [ft]

20/125

Retinal thickness at baseline [µm]

 Mean (SD)

404.2 (134.5)